ZANNETTI, BEATRICE ANNA
 Distribuzione geografica
Continente #
NA - Nord America 1.659
AS - Asia 1.113
EU - Europa 1.058
AF - Africa 111
SA - Sud America 66
Totale 4.007
Nazione #
US - Stati Uniti d'America 1.636
CN - Cina 376
SG - Singapore 361
GB - Regno Unito 241
IT - Italia 190
SE - Svezia 158
VN - Vietnam 155
DE - Germania 142
HK - Hong Kong 71
IN - India 59
RU - Federazione Russa 54
NL - Olanda 52
BR - Brasile 51
FR - Francia 49
CI - Costa d'Avorio 45
IE - Irlanda 41
KR - Corea 39
UA - Ucraina 35
ZA - Sudafrica 28
TG - Togo 23
FI - Finlandia 20
BE - Belgio 19
EE - Estonia 17
BG - Bulgaria 16
CA - Canada 15
JP - Giappone 15
AR - Argentina 9
SC - Seychelles 9
JO - Giordania 8
MX - Messico 7
CH - Svizzera 6
ID - Indonesia 6
NG - Nigeria 6
BD - Bangladesh 4
ES - Italia 4
IR - Iran 4
AT - Austria 3
EC - Ecuador 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
IL - Israele 2
IQ - Iraq 2
LB - Libano 2
LT - Lituania 2
PL - Polonia 2
CL - Cile 1
CO - Colombia 1
GE - Georgia 1
HU - Ungheria 1
KZ - Kazakistan 1
LV - Lettonia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SI - Slovenia 1
TW - Taiwan 1
Totale 4.007
Città #
Singapore 240
Ashburn 220
Southend 207
Chandler 176
Fairfield 170
Hefei 96
Ann Arbor 94
Woodbridge 92
Wilmington 82
Seattle 78
Hong Kong 71
Houston 66
Beijing 53
Cambridge 53
Princeton 46
Abidjan 45
Bologna 43
Dublin 41
Seoul 39
Boardman 34
Dong Ket 34
Santa Clara 34
New York 31
Los Angeles 30
Lomé 23
Westminster 21
Ho Chi Minh City 19
Jinan 19
Padova 19
Brussels 18
Bremen 17
Helsinki 16
Nanjing 16
Sofia 15
Berlin 14
Jacksonville 14
Florence 13
Milan 13
Tokyo 13
Turin 13
Redondo Beach 12
Changsha 11
Frankfurt am Main 11
Redwood City 11
Saint Petersburg 11
Munich 10
San Diego 9
Shenyang 9
Amman 8
Bengaluru 8
Genoa 8
Hanoi 8
Rome 8
Zhengzhou 8
Hyderabad 7
Jiaxing 7
Nanchang 7
Toronto 7
Abeokuta 6
Buffalo 6
Chicago 6
Council Bluffs 6
Dallas 6
Dearborn 6
Guangzhou 6
Paris 6
Phoenix 6
São Paulo 6
Dresden 5
Falls Church 5
Hebei 5
Jakarta 5
London 5
Orem 5
Tianjin 5
Bern 4
Bexley 4
Medford 4
Monmouth Junction 4
Mülheim 4
Nuremberg 4
Ottawa 4
San Francisco 4
Washington 4
Da Nang 3
Falkenstein 3
Imola 3
Indore 3
Kuban 3
Leawood 3
Manchester 3
Martinengo 3
Mumbai 3
Salt Lake City 3
Sansepolcro 3
Shanghai 3
Taiyuan 3
Yubileyny 3
Andover 2
Bari 2
Totale 2.675
Nome #
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease 274
Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma. 236
Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment 230
Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma. 229
Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes 206
Safety and efficacy of daratumumab in dialysis-dependent renal failure secondary to multiple myeloma 181
Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma 171
Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens 171
Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis 168
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma 159
Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome 153
Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents 150
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma 150
Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma. 146
HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment 146
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 145
Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease. 140
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 135
Gene expression analysis of newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted p5 133
Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis. 123
Novel insights and therapeutic approaches in secondary AML 121
SIRT Regulates the Molecular Interaction Between c-MYC and HIF-1α in Multiple Myeloma 119
Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy 116
New Horizons in Immunology and Immunotherapy of Acute Leukemias and Related Disorders 104
Low WT1 Expression Identifies a Subset of Acute Myeloid Leukemia with a Distinct Genotype 86
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 66
Overview on novel strategies and current guidelines for hematopoietic stem cell mobilisation and collection 35
Totale 4.093
Categoria #
all - tutte 11.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.278


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021229 0 0 0 0 0 23 14 20 39 17 17 99
2021/2022520 67 25 26 47 47 19 6 34 13 53 86 97
2022/2023611 54 97 26 97 41 57 11 37 108 15 47 21
2023/2024199 15 23 12 25 16 63 13 9 1 8 6 8
2024/2025651 32 91 54 43 79 28 55 20 7 82 42 118
2025/2026851 173 150 127 151 180 70 0 0 0 0 0 0
Totale 4.093